— Know what they know.
Not Investment Advice

SSKN OTC

STRATA Skin Sciences, Inc.
1W: +0.0% 1M: +0.0% 3M: -96.2% YTD: -99.6% 1Y: -99.7% 3Y: -99.9% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 56 · $23251 mcap · 2M float · 0.529% daily turnover · Short 44% of daily vol

Supply Chain Overview

4 relationships
3
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2021-08-16
Earliest Filing
2022-01-10
Latest Filing
target: 1 acquirer: 1 partner: 1

Counterparties (Filed by SSKN)

3 relationships

Companies named in SSKN's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Theravant Corporation — target Seller of assets in the asset purchase agreement 2022-01-10 View
Strata Skin Sciences, Inc. SSKN acquirer Buyer of assets in the asset purchase agreement 2022-01-10 View
Ladenburg Thalmann & Co. Inc. — partner Sales Agent for the equity distribution agreement 2021-10-18 View

Mentioned As Counterparty

1 mentions

Other companies that named SSKN in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
VTAK Ra Medical Systems, Inc. target Acquired Ra Medical's Pharos laser business for $5,000,000 2021-08-16 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-02-11 Notice of Delisting or Transfer; Other Events View
2025-12-17 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-12-10 Submission of Matters to a Vote of Security Holders View
2025-11-13 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-10-16 Other Events; Financial Statements and Exhibits View
2025-10-14 Notice of Delisting or Transfer View
2025-09-04 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-09-03 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2025-08-22 Notice of Delisting or Transfer View
2025-08-18 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-08-13 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-08-07 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-05-19 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-05-14 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-04-25 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2025-03-27 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2025-03-20 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-12-11 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-11-13 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2024-11-12 Regulation FD Disclosure; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms